Status:
COMPLETED
Role of Topical Putrescine (Fibrostat) for Prevention of Hypertrophic Scars in Mammoplasty Patients
Lead Sponsor:
University of Manitoba
Conditions:
Hypertrophic Scar
Eligibility:
FEMALE
18-80 years
Phase:
PHASE3
Brief Summary
Linked to previous Clinical Trial E92:069 in which biochemical effect of 1,4 diaminobutane was studied in human scar harvested at revision surgery after a 12 week application. Analytical data was coll...
Detailed Description
In this study, patients were "randomized" into one of 2 study groups described below. They agreed to being treated on the right side or the left with active agent, while the other side was to receive ...
Eligibility Criteria
Inclusion
- Undergoing breast reduction surgery -
Exclusion
- Not pregnant or lactating
- \-
Key Trial Info
Start Date :
September 2 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2016
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT03376620
Start Date
September 2 2011
End Date
July 15 2016
Last Update
December 20 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.